CR3-dependent resistance to acute Toxoplasma gondii infection in mice

Infection and Immunity

Volumn 64, Issue 6, 1996, Pages 1998-2003

  Johnson, Lawrence L ^a   Gibson, George W ^b   Sayles, Peter C ^a  

^a TRUDEAU INSTITUTE   (United States)

^b Proctor and Gamble Pharmaceuticals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVITY; CELL SURVIVAL; DISEASE RESISTANCE; FLOW CYTOMETRY; IMMUNITY; MACROPHAGE FUNCTION; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL RATE; TOXOPLASMA GONDII;

EID: 0029935820     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.6.1998-2003.1996     Document Type: Article

References (24)

1. + T cells but not inhibition of the protective activity of IFN-γ prevents cure of toxoplasmosis mediated by drug therapy in mice. J. Immunol. 149:3003-3007.
2. Ault, K. A., and T. A. Springer. 1981. Cross-reaction of a rat-anti-mouse phagocyte-specific monoclonal antibody (ANTI-Mac-1) with human monocytes and natural killer cells. J. Immunol. 126:359-364.
3. Drevets, D. A., P. J. M. Leenen, and P. A. Campbell. 1993. Complement receptor type 3 (CD11b/CD18) involvement is essential for killing of Listeria monocytogenes by mouse macrophages. J. Immunol. 151:5431-5439.
4. Gazzinelli, R. T., S. Hieny, T. A. Wynn, S. Wolf, and A. Sher. 1993. Interleukin 12 is required for the T-lymphocyte-independent induction of interferon γ by an intracellular parasite and induced resistance in T-cell-deficient hosts. Proc. Natl. Acad. Sci. USA 90:6115-6119.
5. Gazzinelli, R. T., M. Wysocka, S. Hayashi, E. Y. Denkers, S. Hieny, P. Caspar, G. Trinchieri, and A. Sher. 1994. Parasite-induced IL-12 stimulates early IFN-γ synthesis and resistance during acute infection with Toxoplasma gondii. J. Immunol. 153:2533-2543.
6. Harmsen, A. G. Personal communication.
7. Hunter, C. A., E. Candolfi, C. Subauste, V. Van Cleave, and J. S. Remington. 1995. Studies on the role of interleukin-12 in acute murine toxoplasmosis. Immunology 84:16-20.
8. Hunter, C. A., C. S. Subauste, V. H. Van Cleave, and J. S. Remington. 1994. Production of gamma interferon by natural killer cells from Toxoplasma gondii-infected SCID mice: regulation by interleukin-10, interleukin-12, and tumor necrosis factor alpha. Infect. Immun. 62:2828-2824.
9. Johnson, L. L. 1992. A protective role for endogenous tumor necrosis factor in Toxoplasma gondii infection. Infect. Immun. 60:1979-1983.
10. Johnson, L. L. Unpublished observation.
11. + lymphocytes. Infect. Immun. 61:5174-5180.
12. Khan, I. A., T. Matsuura, and L. H. Kasper. 1994. Interleukin-12 enhances murine survival against acute toxoplasmosis. Infect. Immun. 62:1639-1642.
13. Langermans, J. A. M., M. E. B. van der Hulst, P. H. Nibbering, P. S. Hiemstra, L. Fransen, and R. van Furth. 1992. IFN-γ-induced L-arginine-dependent toxoplasmastatic activity in murine peritoneal macrophages is mediated by endogenous tumor necrosis factor-α. J. Immunol. 148:568-574.
14. Langermans, J. A. M., M. E. B. van der Hulst, P. H. Nibbering, and R. van Furth. 1992. Endogenous tumor necrosis factor alpha is required for enhanced antimicrobial activity against Toxoplasma gondii and Listeria monocytogenes in recombinant gamma interferon-treated mice. Infect. Immun. 60:5107-5112.
15. + T cells facilitates homing to inflammatory sites. J. Immunol. 153: 2021-2028.
16. Rosen, H. 1990. Role of CR3 in induced myelomonocytic recruitment: insights from in vivo monoclonal antibody studies in the mouse. J. Leukocyte Biol. 48:465-469.
17. Rosen, H., and S. Gordon. 1987. Monoclonal antibody to the murine type 3 complement receptor inhibits adhesion of myelomonocytic cells in vitro and inflammatory cell recruitment in vivo. J. Exp. Med. 166:1685-1701.
18. Rosen, H., S. Gordon, and R. J. North. 1989. Exacerbation of murine listeriosis by monoclonal antibody specific for the type 3 complement receptor of myelomonocytic cells. J. Exp. Med. 170:27-37.
19. Rosen, H., G. Milon, and S. Gordon. 1989. Antibody to the murine type 3 complement receptor inhibits T lymphocyte-dependent recruitment of myelomonocytic cells in vivo. J. Exp. Med. 169:535-548.
20. Ross, G. D., and V. Vetvicka. 1993. CR3 (CD11b, CD18): a phagocyte and NK cell membrane receptor with multiple ligand specificities and functions. Clin. Exp. Immunol. 92:181-184.
21. Sher, A., I. P. Oswald, S. Hieny, and R. T. Gazzinelli. 1993 Toxoplasma gondii induces a T-independent IFN-γ response in natural killer cells that requires both adherent accessory cells and tumor necrosis factor-α. J. Immunol. 150:3982-3989.
22. + T lymphocytes are the major cell population involved in the early gamma interferon response and resistance to acute primary Toxoplasma gondii infection in mice. Microbiol. Immunol. 38:789-796.
23. Sibley, L. D., L. B. Adams, Y. Fukutomi, and J. L. Krahenbuhl. 1991. Tumor necrosis factor-α triggers antitoxoplasmal activity of IFN-γ primed macrophages. J. Immunol. 147:2340-2345.
24. Suzuki, Y., M. A. Orellana, R. D. Schreiber, and J. S. Remington. 1988 Interferon-γ: the major mediator of resistance against Toxoplasma gondii. Science 240:516-518.